AstraZeneca has partnered CICC to launch a fund that will invest in Chinese startups exploiting technologies such as artificial intelligence to improve healthcare.
Pharmaceutical firm AstraZeneca yesterday partnered investment bank China International Capital Corporation (CICC) to create the $1bn Healthcare Industrial Fund and drive healthcare innovation in China.
The Healthcare Industrial Fund will focus on small and medium-sized enterprises and will particularly seek out opportunities in the drug and diagnostics spaces, as well as startups that use artificial intelligence and digital technologies to improve healthcare.
The vehicle will invest in domestic firms and international businesses looking to expand into China. AstraZeneca is particularly…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
